| Bioactivity | Val-Ala-PABC-Exatecan trifluoroacetate is a Drug-Linker Conjugates for ADC，consiting of a cleavable Tesirine linker (Val-Ala-PABC) and Exatecan (topoisomerase I inhibitor，HY-13631). Val-Ala-PABC-Exatecan trifluoroacetate can be used for ADC molecues synthesis，such as Mal-PEGn-amide-va-Exatecan[1]. |
| Name | Val-Ala-PABC-Exatecan trifluoroacetate |
| CAS | 2928571-45-1 |
| Formula | C42H44F4N6O10 |
| Molar Mass | 868.83 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Cheng X, et al. MORAb-202, an Antibody-Drug Conjugate Utilizing Humanized Anti-human FRα Farletuzumab and the Microtubule-targeting Agent Eribulin, has Potent Antitumor Activity. Mol Cancer Ther. 2018 Dec;17(12):2665-2675. |
Val-Ala-PABC-Exatecan trifluoroacetate
CAS: 2928571-45-1 F: C42H44F4N6O10 W: 868.83
Val-Ala-PABC-Exatecan trifluoroacetate is a Drug-Linker Conjugates for ADC，consiting of a cleavable Tesirine linker (Va
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.